Philips Launches RADIQAL Study to Generate Real-world Evidence for New Ultra-low X-ray Dose Technology in Coronary Procedures

This multicenter, randomized study, sponsored by Philips will enroll 824 coronary artery disease patients across 6 hospitals in Spain, Czech Republic and the US. The first patient in the study was enrolled at Aarhus University Hospital, Denmark.